Murine osteoclastogenesis suppression using conditioned media produced by melanoma or activated and non-activated

Nicole C Mambelli-Lisboa1,2, Eduardo O Frare1,2, Adriana da Costa-Neves1,2

  • 1Laboratory of Genetics, Butantan Institute, São Paulo, Brazil.

Insights

Conditioned medium (CM) from activated immune cells, particularly Jurkat-E6 cells, significantly inhibits osteoclast formation. This effect is linked to higher levels of interferon gamma (IFN-γ), a key inhibitor of osteoclastogenesis.

Area of Science:

  • Cell Biology
  • Immunology
  • Bone Biology

Background:

  • Conditioned medium (CM) contains soluble mediators influencing cellular processes.
  • Osteoclasts are crucial for bone resorption, and their differentiation can be modulated by various cell types.
  • Immune and cancer cells secrete factors that impact osteoclast differentiation.

Purpose of the Study:

  • To investigate the effect of CM from different cell lines on osteoclast differentiation.
  • To compare the inhibitory potential of CM from activated and non-activated Jurkat-E6 cells, and from melanoma cell lines.
  • To identify specific factors within CM, such as IFN-γ, that mediate osteoclastogenesis inhibition.

Main Methods:

  • Murine bone marrow mononuclear cells were cultured to induce osteoclast differentiation.
  • CM from activated/non-activated Jurkat-E6, B16-F10 (murine melanoma), and SK-MEL-28 (human melanoma) cells were applied.
  • Concentrations of IL-6, TNF-α, and IFN-γ in CM were measured.
  • Osteoclast formation was assessed at early and intermediate differentiation stages.

Main Results:

  • CM from all tested cell lines suppressed osteoclast formation.
  • CM from activated Jurkat-E6 cells exhibited a stronger inhibitory effect than CM from naive Jurkat-E6 or melanoma cells.
  • Activated Jurkat-E6 CM showed significantly higher IFN-γ secretion compared to other CMs.
  • B16-F10 derived CM had a comparatively weaker inhibitory effect.

Conclusions:

  • CM, especially from activated immune cells like Jurkat-E6, effectively inhibits osteoclast differentiation.
  • IFN-γ is a key mediator in the observed inhibition of osteoclastogenesis by activated Jurkat-E6 CM.
  • The study highlights the potential of specific cell secretomes in modulating bone resorption processes.

Related Concept Videos